SARS-CoV-2 omicron variant vaccine (University of Adelaide)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameSARS-CoV-2 omicron variant vaccine (University of Adelaide)
Drug Alias NameDNA-based COVID-19 booster vaccine (University of Adelaide)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsNo
Global Highest StatusClinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Adelaide
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Adelaide
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A